NEON THERAPEUTICS, INC. Capital Expenditures
NEON THERAPEUTICS, INC. reported Capital Expenditures of $9.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2020-05-01
- NEON THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2020-03-31 was $9.00K, a 99.12% decline year-over-year.
- NEON THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-12-31 was -$183.00K, a 129.80% decline year-over-year.
- NEON THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-09-30 was $62.00K, a 81.38% decline year-over-year.
- NEON THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-06-30 was $179.00K, a 78.09% decline year-over-year.
- NEON THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2019 was $1.08M, a 66.36% decline from fiscal 2018.
- NEON THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2018 was $3.22M, a 0.62% decline from fiscal 2017.
- NEON THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2017 was $3.24M, a 35.31% increase from fiscal 2016.
- NEON THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2016 was $2.40M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2020-03-31 | $9.00K 10-Q · filed 2020-05-01 | -$174.00K derived: sum of 2 quarters · filed 2020-05-01 | -$112.00K derived: sum of 3 quarters · filed 2020-05-01 | $67.00K derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-12-31 | -$183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$121.00K derived: sum of 2 quarters · filed 2020-03-02 | $58.00K derived: sum of 3 quarters · filed 2020-03-02 | $1.08M 10-K · filed 2020-03-02 |
| 2019-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $241.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.27M 10-Q · filed 2019-11-12 | $1.88M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-06-30 | $179.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $1.21M 10-Q · filed 2019-08-06 | $1.82M derived: sum of 3 quarters · filed 2020-05-01 | $2.15M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-03-31 | $1.03M 10-Q · filed 2020-05-01 | $1.64M derived: sum of 2 quarters · filed 2020-05-01 | $1.97M derived: sum of 3 quarters · filed 2020-05-01 | $2.79M derived: sum of 4 quarters · filed 2020-05-01 |
| 2018-12-31 | $614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $947.00K derived: sum of 2 quarters · filed 2020-03-02 | $1.76M derived: sum of 3 quarters · filed 2020-03-02 | $3.22M 10-K · filed 2020-03-02 |
| 2018-09-30 | $333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.15M derived: sum of 2 quarters · filed 2019-11-12 | $2.61M 10-Q · filed 2019-11-12 | $3.09M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $817.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.27M 10-Q · filed 2019-08-06 | $2.76M derived: sum of 3 quarters · filed 2019-08-06 | $3.39M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $1.46M 10-Q · filed 2019-05-13 | $1.94M derived: sum of 2 quarters · filed 2019-05-13 | $2.57M derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | $486.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $1.11M derived: sum of 2 quarters · filed 2019-03-11 | $3.24M 10-K · filed 2019-03-11 | |
| 2017-09-30 | $627.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $2.76M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $2.13M 10-Q · filed 2018-08-06 | |||
| 2016-12-31 | $2.40M 10-K · filed 2019-03-11 |